# Utility of neutrophil gelatinase-associated lipocalin in identifying septic cavitary effusions in dogs

**Authors:** Rachel Meyer, Erin McQuinn, Amanda Kreuder, Alan Hassall, Jean-Sebastien Palerme

PMC · DOI: 10.1093/jvimsj/aalaf083 · Journal of Veterinary Internal Medicine · 2026-02-11

## TL;DR

This study shows that measuring NGAL in body fluids can help identify septic effusions in dogs, similar to its use in humans.

## Contribution

The study demonstrates that NGAL in effusions is a novel and effective marker for septic effusions in dogs.

## Key findings

- Effusion NGAL concentrations were significantly higher in septic cases compared to other causes of effusion.
- Serum NGAL levels did not differ significantly between groups, but effusion NGAL levels were diagnostic for sepsis.

## Abstract

Neutrophil gelatinase-associated lipocalin (NGAL) is an accurate marker of septic cavitary effusions in people.

To evaluate the utility of serum and effusion NGAL concentrations in differentiating septic effusions from effusions caused by other etiologies in dogs.

Fifty dogs with pleural or peritoneal effusion.

Ten dogs were prospectively enrolled into each of 5 groups based on effusion etiology: hypoalbuminemia, increased hydrostatic pressure, neoplastic, inflammatory, and septic. Concentrations of NGAL were measured in both serum and effusion.

While median serum NGAL concentrations did not significantly differ between dogs with hypoalbuminemia (24.8 ng/mL, range 5.0–110.0 ng/mL), increased hydrostatic pressure (13.2 ng/mL, range 5.8–46.9 ng/mL), abdominal neoplasia (13.8 ng/mL, range 3.2–27.3 ng/mL), inflammatory (15.8 ng/mL, 5.6–36.6 ng/mL), or septic causes (19.2 ng/mL, range 7.2–64.8 ng/mL) of effusion (P = .272), median effusion NGAL concentrations were significantly higher in the septic group (194.4 ng/mL, range 120.0–1471.1ng/mL) than in the hypoalbuminemic (10.7 ng/mL, range 4.1–27.8 ng/mL, P < .001), hydrostatic (22.7 ng/mL, range 11.3–56.7 ng/mL, P < .001), neoplastic (65 ng/mL, range 15.7–215.3 ng/mL, P < .001), or inflammatory (45 ng/mL, range 33.8–195 ng/mL, P < .001) groups.

Concentrations of NGAL in effusions were significantly higher in septic effusions than in effusions of other etiologies. These findings suggest that effusion NGAL concentrations could be a helpful marker in the identification of cases with septic effusion.

## Linked entities

- **Proteins:** LCN2 (lipocalin 2)

## Full-text entities

- **Genes:** LCN2 (lipocalin 2) [NCBI Gene 3934] {aka 24p3, MSFI, NGAL, p25}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 403981], ALB (albumin) [NCBI Gene 403550] {aka CSA}, IL10 (interleukin 10) [NCBI Gene 403628] {aka IL-10}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 403850] {aka IL8}, IL6 (interleukin 6) [NCBI Gene 403985] {aka IL-6}, LCN2 (lipocalin 2) [NCBI Gene 491320]
- **Diseases:** SIRS (MESH:D018746), carcinoma (MESH:D009369), articular inflammation (MESH:D007249), circulatory shock (MESH:D012769), critically ill (MESH:D016638), hypoalbuminemia (MESH:D034141), AKI (MESH:D058186), pleural effusion (MESH:D010996), cavitary effusion (MESH:C566924), infection (MESH:D007239), effusion (MESH:D000080324), Septic peritonitis (MESH:D010538), intervertebral disc disease (MESH:C535531), portal hypertension (MESH:D006975), epithelial neoplasia (MESH:D009375), TNCC (MESH:D002292), sepsis (MESH:D018805), Septic (MESH:D001170), ovarian carcinomas (MESH:D010051), Systemic (MESH:D015619), lymphoma (MESH:D008223), heart failure (MESH:D006333)
- **Chemicals:** lactate (MESH:D019344), TP (-), glucose (MESH:D005947), creatinine (MESH:D003404), LPS (MESH:D008070)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Felis catus (cat, species) [taxon 9685], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Equus caballus (domestic horse, species) [taxon 9796]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12893216/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12893216/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12893216/full.md

---
Source: https://tomesphere.com/paper/PMC12893216